Ownership

Sath Shukla - Insider Trading & Ownership

Entity: Individual
Location: C/O Ziopharm Oncology, Inc., One First Avenue, Parris Building #34, Boston, MA
Summary: The estimated net worth of Sath Shukla is at least $1.35M dollars as of February 5, 2025. Sath Shukla is the CEO & President of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $1.35M.
All Insider Reports: All Insider Reports

Ownership of Sath Shukla

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SPRO	Spero Therapeutics, Inc.	CEO & President	$1.35M	-$168K	-11%	Feb 3, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Sath Shukla:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.